ceel.ai conducted an ATTR-CM analysis showing one medicine stayed first across both tested approaches.
Published
Signal category
Research & Knowledge
Quote
“In our ATTR-CM analysis, one medicine stayed first across both tested approaches.”
— Andreas Gensch|ceel.ai team
Company
ceel.ai
Lead every healthcare decision. The LLM platform that transforms pharma's AI engagement into a competitive advantage
- Industry
- Hospitals and Health Care
- Company size
- 3 employees
Empowering Brands with Advanced LLM Analytics At ceel.ai, we provide brands with actionable insights through our cutting-edge LLM analytics platform. As the digital landscape shifts from traditional search engines to large language models (LLMs) for recommendations and answers, brands face a new challenge: ensuring accurate and impactful representation in LLM-driven responses. Our solution is designed to bridge this gap, offering brands in the Consumer Goods sector the tools they need to monitor, analyze, and optimize how they’re portrayed across various LLM platforms. By leveraging prompt variations and data-driven insights, ceel.ai delivers a clear view of brand visibility, competitive positioning, and market dynamics. We’re on a mission to help brands thrive in the era of AI-powered interactions, providing clarity in a space where consistency and context are crucial for growth. Let’s redefine brand presence together. ceel.ai - The AI brand intelligence company
Founded 2025